Cover Image

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Fabrizio Martora, Teresa Battista, Claudio Marasca, Lucia Genco, Gabriella Fabbrocini, Luca Potestio Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence: Fabrizio Martora, Section of Dermatology, Department of Clinical Me...

Full description

Saved in:

Bibliographic Details
Main Authors:	Martora F (Author), Battista T (Author), Marasca C (Author), Genco L (Author), Fabbrocini G (Author), Potestio L (Author)
Format:	Book
Published:	Dove Medical Press, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
by: Potestio L, et al.
Published: (2023)

Hidradenitis suppurativa flares following COVID-19 vaccination: A case series
by: Fabrizio Martora, MD, et al.
Published: (2022)

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
by: Potestio L, et al.
Published: (2023)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
by: Martora F, et al.
Published: (2023)

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
by: Ruggiero A, et al.
Published: (2022)

Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments
by: Battista T, et al.
Published: (2023)

Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
by: Potestio L, et al.
Published: (2024)

Heterogeneous cutaneous reactions following COVID-19 vaccination and infection
by: Shin-Shin Ho, et al.
Published: (2024)

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
by: Martora F, et al.
Published: (2024)

Cutaneous hypersensitivity reaction with acute hepatitis following COVID-19 vaccine
by: Christine Y. Wong, MD, et al.
Published: (2021)

Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study
by: Matteo M, et al.
Published: (2023)

Herpes Zoster and COVID-19 Vaccination: A Narrative Review
by: Potestio L, et al.
Published: (2023)

Histopathological spectrum of cutaneous reactions following COVID-19 Vaccine - An observational study
by: Alpana Mohta, et al.
Published: (2023)

Cutaneous reactions post‐COVID‐19 vaccination. Case series and literature review
by: Fatimah J. Al‐Muqarrab, et al.
Published: (2022)

Cutaneous reaction reported after third Moderna COVID-19 vaccine
by: Sophie H. Guénin, MSc, et al.
Published: (2021)

The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
by: Potestio L, et al.
Published: (2024)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
by: Potestio L, et al.
Published: (2023)

Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines
by: Dennis Niebel, et al.
Published: (2021)

Cutaneous reactions to COVID-19 vaccines: A reviewCapsule Summary
by: See Wei Tan, MBBS, MRCP, et al.
Published: (2022)

Cutaneous Reactions after COVID-19 Vaccines: Analysis of the Clinical and Histopathological Spectrum-Case Series and Review of the Literature
by: Ursina Schmid, et al.
Published: (2024)

The Past, the Present and the Future of Teledermatology: A Narrative Review
by: Tommasino N, et al.
Published: (2024)

Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report
by: Martora F, et al.
Published: (2024)

Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
by: Martora F, et al.
Published: (2024)

Cutaneous leukocytoclastic vasculitis following COVID‐19 vaccination
by: Manuel Zoppi, et al.
Published: (2023)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
by: Ruggiero A, et al.
Published: (2022)

A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine
by: Kristen Lospinoso, BS, et al.
Published: (2021)

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
by: Megna M, et al.
Published: (2023)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
by: Martora F, et al.
Published: (2023)

Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
by: Manila Purushottam, et al.
Published: (2023)

Prior antihistamine agent successfully impaired cutaneous adverse reactions to COVID‐19 vaccine
by: Hikaru Nanamori, et al.
Published: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
by: Potestio L, et al.
Published: (2023)

Towards Personalized Medicine in Psoriasis: Current Progress
by: Camela E, et al.
Published: (2022)

Systemic Sarcoidosis with Cutaneous Tattoo Involvement Following COVID-19 Vaccination
by: Carolin Constanze Albers, et al.
Published: (2023)

Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy
by: Salma El-Behaedi, BS, et al.
Published: (2022)

A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology
by: G. Alden Holmes, MD, et al.
Published: (2021)

Risk Factors for Psoriasis Flares: A Narrative Review
by: Potestio L, et al.
Published: (2024)

Reactive arthritis following vaccination against COVID-19: An unexpected adverse reaction
by: Diksha Agrawal, et al.
Published: (2023)

Transient dermatomyositis-like reaction following COVID-19 messenger RNA vaccination
by: Rodrigo A. Gutierrez, BS, et al.
Published: (2023)

Cutaneous mucormycosis following COVID-19 vaccination in a patient with bullous pemphigoid
by: Kishan M. Shah, MD, et al.
Published: (2021)

The cutaneous manifestations related to COVID-19 infection and vaccination: current aspects and future prospects
by: Sheng-Hsiang Ma, et al.
Published: (2021)